Article 07 Aug 2026 Understanding The Judges Of The US Court Of Appeals For The Federal Circuit, Senior Status, And The Rule Of 80 United States IP
Article 11 Mar 2026 The Supreme Court's "Skinny Label" Showdown: What Hikma v. Amarin Means For Generic Drug Companies United States Healthcare
Article 21 Nov 2025 FDA's Move To Streamline Biosimilar Approval: What In-House Counsel Must Prepare For Now United States IP
Article 17 Oct 2025 Conception & Inventorship Under Pharmaceutical Patent Law: Lessons And Best Practices United States IP
Article 01 Aug 2025 Preserving Attorney-Client Privilege In Mergers And Acquisitions: Navigating The Common Interest Doctrine United States Commercial
Article 27 Jun 2025 Your Rights If FDA Agreed To Your Proposed Q1/Q2 ANDA Formulation But Sends A Refuse To Receive (RTR) Instead? United States Healthcare
Article 19 Mar 2025 Patent & Regulatory Legal Issues Related To Fertilizers, Fungicides, Pesticides, & Bulk Chemicals United States IP
Article 17 Mar 2025 Intellectual Property Issues Related To Artificial Intelligence: A Deeper Dive Into Patent, Copyright, & Trade Secrets Challenges United States IP
Article 10 Jan 2025 Pending 2025 FDA Legislation On Pharmaceutical Development & Marketing: A Comprehensive Industry Impact Analysis United States Healthcare
Article 19 Nov 2024 Infringing Your Own Intellectual Property: Understanding The Paradox United States IP
Article 17 Oct 2024 Proving Patent Infringement – Double Counting Pharmaceutical Ingredients When One Element Satisfies Two Claim Limitations United States IP
Article 28 Aug 2024 The Right To Repair Versus Reconstruction Under U.S. Patent Law: An In-Depth Analysis United States IP
Article 24 Jul 2024 Data Falsification/Data Integrity - You Can Run But You Cannot Hide United States Healthcare
Article 17 Jun 2024 Navigating Administrative Law: Understanding The Basics Of Challenging Federal Agency Decisions United States Healthcare